Literature DB >> 22039327

Does the bile duct angulation affect recurrence of choledocholithiasis?

Dong Beom Seo1, Byoung Wook Bang, Seok Jeong, Don Haeng Lee, Shin Goo Park, Yong Sun Jeon, Jung Il Lee, Jin-Woo Lee.   

Abstract

AIM: To investigate whether bile duct angulation and T-tube choledochostomy influence the recurrence of choledocholithiasis.
METHODS: We conducted a retrospective study inclu-ding 259 patients who underwent endoscopic sphincterotomy and cholecystectomy for choledocholithiasis between 2000 and 2007. The imaginary line was drawn along the center of the bile duct and each internal angle was measured at the two angulation sites of the bile duct respectively. The values of both angles were added together. We then tested our hypothesis by examining whether T-tube choledochostomy was performed and stone recurrence occurred by reviewing each subject's medical records.
RESULTS: The overall recurrence rate was 9.3% (24 of 259 patients). The mean value of sums of angles in the recurrence group was 268.3° ± 29.6°, while that in the non-recurrence group was 314.8° ± 19.9° (P < 0.05). Recurrence rate of the T-tube group was 15.9% (17 of 107), while that of the non T-tube group was 4.6% (7 of 152) (P < 0.05). Mean value of sums of angles after T-tube drainage was 262.5° ± 24.6° and that before T-tube drainage was 298.0° ± 23.9° in 22 patients (P < 0.05).
CONCLUSION: The bile duct angulation and T-tube choledochostomy may be risk factors of recurrence of bile duct stones.

Entities:  

Keywords:  Cholecystectomy; Choledocholithiasis; Common bile duct; Endoscopic retrograde cholangio pancreatography; Recurrence

Mesh:

Year:  2011        PMID: 22039327      PMCID: PMC3203364          DOI: 10.3748/wjg.v17.i36.4118

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  [Endoscopic sphincterotomy of the papilla of vater and extraction of stones from the choledochal duct (author's transl)].

Authors:  M Classen; L Demling
Journal:  Dtsch Med Wochenschr       Date:  1974-03-15       Impact factor: 0.628

2.  Endoscopic sphincterotomy of the ampulla of Vater.

Authors:  K Kawai; Y Akasaka; K Murakami; M Tada; Y Koli
Journal:  Gastrointest Endosc       Date:  1974-05       Impact factor: 9.427

3.  Association between cholangiographic angulation of the common bile duct and choledocholithiasis.

Authors:  B L Warren
Journal:  S Afr J Surg       Date:  1987-03       Impact factor: 0.375

4.  Endoscopic sphincterotomy: follow-up evaluation of effects on the sphincter of Oddi.

Authors:  J E Geenen; J Toouli; W J Hogan; W J Dodds; E T Stewart; P Mavrelis; D Riedel; R Venu
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

5.  Recurrent cholangitis after biliary surgery.

Authors:  L D Goldman; M L Steer; W Silen
Journal:  Am J Surg       Date:  1983-04       Impact factor: 2.565

6.  An angulated common bile duct predisposes to recurrent symptomatic bile duct stones after endoscopic stone extraction.

Authors:  D Keizman; M I Shalom; F M Konikoff
Journal:  Surg Endosc       Date:  2006-07-20       Impact factor: 4.584

7.  Inhibition of cholesterol crystallization under bilirubin deconjugation: partial characterization of mechanisms whereby infected bile accelerates pigment stone formation.

Authors:  Kuniharu Nakai; Susumu Tazuma; Tomoji Nishioka; Kazuaki Chayama
Journal:  Biochim Biophys Acta       Date:  2003-06-10

8.  Effects of sphincteroplasty and endoscopic sphincterotomy on the bacteriologic characteristics of the common bile duct.

Authors:  J A Gregg; P De Girolami; D L Carr-Locke
Journal:  Am J Surg       Date:  1985-05       Impact factor: 2.565

9.  Biliary sequelae of endoscopic sphincterotomy.

Authors:  C Greenfield; P Cleland; R Dick; S Masters; J A Summerfield; S Sherlock
Journal:  Postgrad Med J       Date:  1985-03       Impact factor: 2.401

10.  Prognostic factors for recurrence of bile duct stones after endoscopic treatment by sphincter dilation.

Authors:  Norio Ueno; Yoshifumi Ozawa; Toshiyuki Aizawa
Journal:  Gastrointest Endosc       Date:  2003-09       Impact factor: 9.427

View more
  7 in total

1.  Topical nitrate drip infusion using cystic duct tube for retained bile duct stone: A six patients case series.

Authors:  Masatoshi Shoji; Hiroshi Sakuma; Yutaka Yoshimitsu; Tsutomu Maeda; Masuo Nakai; Hiroshi Ueda
Journal:  World J Gastrointest Surg       Date:  2013-06-27

2.  Recurrence of choledocholithiasis following endoscopic bile duct clearance: Long term results and factors associated with recurrent bile duct stones.

Authors:  Christos Konstantakis; Christos Triantos; Vasileios Theopistos; Georgios Theocharis; Ioannis Maroulis; Georgia Diamantopoulou; Konstantinos Thomopoulos
Journal:  World J Gastrointest Endosc       Date:  2017-01-16

3.  New common bile duct morphological subtypes: Risk predictors of common bile duct stone recurrence.

Authors:  Xu Ji; Zhuo Yang; Shu-Ren Ma; Wen Jia; Qian Zhao; Lu Xu; Ying Kan; Yang Cao; Yao Wang; Bao-Jun Fan
Journal:  World J Gastrointest Surg       Date:  2022-03-27

4.  Risk prediction of common bile duct stone recurrence based on new common bile duct morphological subtypes.

Authors:  Hirokazu Saito; Shuji Tada
Journal:  World J Gastrointest Surg       Date:  2022-08-27

5.  Ectopic opening of the common bile duct into the duodenal bulb with recurrent choledocholithiasis: A case report.

Authors:  Hao Xu; Xin Li; Ke-Xiang Zhu; Wen-Ce Zhou
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

6.  Different Types of Periampullary Duodenal Diverticula Are Associated with Occurrence and Recurrence of Bile Duct Stones: A Case-Control Study from a Chinese Center.

Authors:  Zhen Sun; Wenhui Bo; Ping Jiang; Quan Sun
Journal:  Gastroenterol Res Pract       Date:  2016-04-06       Impact factor: 2.260

7.  Risk factors for recurrence of common bile duct stones after endoscopic biliary sphincterotomy.

Authors:  Sujuan Li; Bingzhong Su; Ping Chen; Jianyu Hao
Journal:  J Int Med Res       Date:  2018-06-04       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.